← Eichor
Study identifier: NCT07611240 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Sevoflurane vs Propofol Anesthesia in Obese Patients Undergoing Lumbar Surgery

Condition: Obesity & Overweight · Lumbar Spine Surgery  ·  Sponsor: Ataturk University

PhaseNA
Planned participants70
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This randomized, single-center, single-masked clinical trial aims to compare the immunomodulatory effects of sevoflurane-based inhalational anesthesia and propofol-based total intravenous anesthesia in obese patients undergoing elective lumbar instrumentation surgery. Seventy patients will be randomized into two groups: a propofol group and a sevoflurane group. Blood samples will be collected preoperatively, at postoperative 6 hours, and at postoperative 24 hours. Pentraxin-3 and serum amyloid A levels will be evaluated as primary inflammatory biomarkers together with IL-6, TNF-α, CRP, glucose, and complete blood count parameters.

This description comes directly from the study's public registry record.

Talk to the study team

Mehmet Akif Yilmaz, Doctor  ·  +905346533539  ·  mehmetakifyilmaz025@gmail.com

Ayşe Ceren Hilal Güven, assistant doctor  ·  554-112-25-81  ·  achg1995@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Ataturk UniversityErzurum, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07611240